Scott Gottlieb and Luciana Borio, a former director for medical and biodefense preparedness policy at the National Security ...
Trump's staff is laying the groundwork to prepare for a new FDA commissioner and make their mark at the agency.
HealthDay on MSN4d
FDA approves Gemtesa for overactive bladder in men with BPHGemtesa is approved for men with overactive bladder symptoms who are receiving pharmacologic treatment for benign prostatic hyperplasia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback